A novel design process for selection of attributes for inclusion in discrete choice experiments: case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke

被引:31
作者
De Brun, Aoife [1 ,2 ]
Flynn, Darren [1 ]
Ternent, Laura [1 ]
Price, Christopher I. [3 ,4 ]
Rodgers, Helen [5 ,6 ]
Ford, Gary A. [5 ,7 ]
Rudd, Matthew [5 ,6 ]
Lancsar, Emily [8 ]
Simpson, Stephen [9 ]
Teah, John [9 ]
Thomson, Richard G. [1 ]
机构
[1] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England
[2] Univ Coll Dublin, Sch Nursing Midwifery & Hlth Syst, Dublin, Ireland
[3] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne Hosp NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[4] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England
[5] Newcastle Univ, Inst Neurosci, Stroke Res Grp, Newcastle Upon Tyne, Tyne & Wear, England
[6] Northumbria Healthcare NHS Fdn Trust, Ashington, England
[7] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[8] Australian Natl Univ, Res Sch Populat Hlth, Dept Hlth Serv Res & Policy, Canberra, ACT, Australia
[9] Stroke Assoc, Gateshead, Australia
基金
美国国家卫生研究院;
关键词
Discrete choice experiment; Intravenous thrombolysis; Clinical decision-making; Acute ischaemic stroke; Design process; Methodology; Patient vignettes; TISSUE-PLASMINOGEN ACTIVATOR; INTRAVENOUS THROMBOLYSIS; HEALTH-CARE; QUALITATIVE RESEARCH; POOLED ANALYSIS; TASK-FORCE; TRIALS; ASSOCIATION; MANAGEMENT; BARRIERS;
D O I
10.1186/s12913-018-3305-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: A discrete choice experiment (DCE) is a method used to elicit participants' preferences and the relative importance of different attributes and levels within a decision-making process. DCEs have become popular in healthcare; however, approaches to identify the attributes/levels influencing a decision of interest and to selection methods for their inclusion in a DCE are under-reported. Our objectives were: to explore the development process used to select/present attributes/levels from the identified range that may be influential; to describe a systematic and rigorous development process for design of a DCE in the context of thrombolytic therapy for acute stroke; and, to discuss the advantages of our five-stage approach to enhance current guidance for developing DCEs. Methods: A five-stage DCE development process was undertaken. Methods employed included literature review, qualitative analysis of interview and ethnographic data, expert panel discussions, a quantitative structured prioritisation (ranking) exercise and pilot testing of the DCE using a 'think aloud' approach. Results: The five-stage process reported helped to reduce the list of 22 initial patient-related factors to a final set of nine variable factors and six fixed factors for inclusion in a testable DCE using a vignette model of presentation. Conclusions: In order for the data and conclusions generated by DCEs to be deemed valid, it is crucial that the methods of design and development are documented and reported. This paper has detailed a rigorous and systematic approach to DCE development which may be useful to researchers seeking to establish methods for reducing and prioritising attributes for inclusion in future DCEs.
引用
收藏
页数:14
相关论文
共 38 条
[1]   Developing attributes and attribute-levels for a discrete choice experiment on micro health insurance in rural Malawi [J].
Abiiro, Gilbert Abotisem ;
Leppert, Gerald ;
Mbera, Grace Bongololo ;
Robyn, Paul J. ;
De Allegri, Manuela .
BMC HEALTH SERVICES RESEARCH, 2014, 14
[2]  
[Anonymous], 2009, COCHRANE DATABASE SY
[3]  
[Anonymous], 2012, SINAP LATEST RESULTS
[4]   Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force [J].
Bridges, John F. P. ;
Hauber, A. Brett ;
Marshall, Deborah ;
Lloyd, Andrew ;
Prosser, Lisa A. ;
Regier, Dean A. ;
Johnson, F. Reed ;
Mauskopf, Josephine .
VALUE IN HEALTH, 2011, 14 (04) :403-413
[5]  
Coast Joanna, 2007, J Health Serv Res Policy, V12, P25, DOI 10.1258/135581907779497602
[6]   Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations [J].
Coast, Joanna ;
Al-Janabi, Hareth ;
Sutton, Eileen J. ;
Horrocks, Susan A. ;
Vosper, A. Jane ;
Swancutt, Dawn R. ;
Flynn, Terry N. .
HEALTH ECONOMICS, 2012, 21 (06) :730-741
[7]   Understanding clinicians' decisions to offer intravenous thrombolytic treatment to patients with acute ischaemic stroke: a protocol for a discrete choice experiment [J].
De Brun, Aoife ;
Flynn, Darren ;
Joyce, Kerry ;
Ternent, Laura ;
Price, Christopher ;
Rodgers, Helen ;
Ford, Gary A. ;
Lancsar, Emily ;
Rudd, Matthew ;
Thomson, Richard G. .
BMJ OPEN, 2014, 4 (07)
[8]   Unequal Access to Treatment With Intravenous Alteplase for Women With Acute Ischemic Stroke [J].
de Ridder, Inger ;
Dirks, Maaike ;
Niessen, Louis ;
Dippel, Diederik .
STROKE, 2013, 44 (09) :2610-2612
[9]   Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study [J].
Dirks, Maaike ;
Niessen, Louis W. ;
Koudstaal, Peter J. ;
Franke, Cees L. ;
van Oostenbrugge, Robert J. ;
Dippel, Diederik W. J. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (07) :685-689
[10]   Barriers to the utilization of thrombolysis for acute ischaemic stroke [J].
Eissa, A. ;
Krass, I. ;
Bajorek, B. V. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (04) :399-409